by Felix Myhill – RegMedNet
Researchers at the University of California, Los Angeles (UCLA; CA, USA) have produced safe and effective allogeneic immune cells that one day may be mobilized to combat cancer.
Allogeneic cell therapies differ from autologous cell therapies as they utilize cells derived from a healthy donor, as opposed to patient-derived cells that have been engineered to confer therapeutic effects.
